Terms: = Cervical cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Prognosis
3 results:
1. Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer.
Kong X; Xiong Y; Xue M; He J; Lu Q; Chen M; Li L
Sci Rep; 2023 Jul; 13(1):10697. PubMed ID: 37400520
[TBL] [Abstract] [Full Text] [Related]
2. Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer.
Wang J; Mijiti Y; Chen Y; Liu Z
Bioengineered; 2021 Dec; 12(2):11922-11935. PubMed ID: 34784845
[TBL] [Abstract] [Full Text] [Related]
3. Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix.
Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
Cancer Lett; 2000 Sep; 158(1):61-4. PubMed ID: 10940510
[TBL] [Abstract] [Full Text] [Related]
